Journal article

Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13

Sarah L Spain, Luis G Carvajal-Carmona, Kimberley M Howarth, Angela M Jones, Zhan Su, Jean-Baptiste Cazier, Jennet Williams, Lauri A Aaltonen, Paul Pharoah, David J Kerr, Jeremy Cheadle, Li Li, Graham Casey, Pavel Vodicka, Oliver Sieber, Lara Lipton, Peter Gibbs, Nicholas G Martin, Grant W Montgomery, Joanne Young Show all

Human Molecular Genetics | OXFORD UNIV PRESS | Published : 2012

Grants

Awarded by Wellcome Trust Centre for Human Genetics, Oxford


Awarded by Medical Research Council


Awarded by Scottish Executive Chief Scientist's Office


Awarded by Fondo de Investigacion Sanitaria/FEDER


Awarded by Ministerio de Ciencia e Innovacion


Awarded by Fondo de Investigacion Sanitaria


Awarded by Cancer Research UK


Funding Acknowledgements

Funding was primarily provided by Cancer Research UK. The EU FP7 CHIBCHA grant supported LGC-C through funding to IPMT, SC-B and ACar. Core infrastructure support to the Wellcome Trust Centre for Human Genetics, Oxford was provided by grant 090532/Z/09/Z. I. P. M. T. received support from the Oxford NIHR Comprehensive Biomedical Research Centre. The UK National Cancer Research Network supported the NSCCG. Additional funding to M. D. was provided by the Medical Research Council (G0000657-53203), CORE and Scottish Executive Chief Scientist's Office (K/OPR/2/2/D333, CZB/4/449). The EPICOLON work was supported by grants from the Fondo de Investigacion Sanitaria/FEDER (08/0024, 08/1276, PS09/02368), Ministerio de Ciencia e Innovacion (SAF2010-19273), Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona) and Fundacio Olga Torres (CRP). S.C.-B. and C.F.-R. are supported by contracts from the Fondo de Investigacion Sanitaria (CP03-0070 and PS09/02368). CIBERehd and CIBERER are funded by the Instituto de Salud Carlos III. For the Melbourne cases, work was supported by the Hilton Ludwig Cancer Metastasis Initiative. The specimens and data from Australian colon cancer patients were provided by the Victorian Cancer Biobank and BioGrid Australia with appropriate ethics approval. The Victorian Cancer Biobank is supported by the Victorian Government. CERA receives operational infrastructure support from the Victorian Government. Funding to pay the Open Access publication charges for this article was provided by the Wellcome Trust.